May 25th, 2022 (Earnings Report)Dear Reader,
HealthTechMovers.com just identified several healthtech stocks that are expected to release earnings starting today, May 25th.If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Enanta Pharmaceuticals
Symbol: ENTA
Recent Price: $45.87
Average Analyst Price Target: $90.20 (96.64%)
Last Year's EPS: -$1.22
Consensus EPS Forecast: -$1.31
Expected Earnings Date: Nov 20 2022
Recent Analyst Action: Brian Skorney, analyst at Robert W. Baird, reiterates coverage on Enanta Pharmaceuticals (ENTA) in the Healthcare sector with a Buy rating and a price target of $ 90 (1 week ago).
Click for complete article >>--------------------------------------------------------------------------
Enlivex Therapeutics
Symbol: ENLV
Recent Price: $4.8
Average Analyst Price Target: $15.00 (212.50%)
Last Year's EPS: -$0.21
Consensus EPS Forecast: -$0.29
Expected Earnings Date: Nov 20 2022
Recent Analyst Action: Ram Selvaraju, analyst at H.C. Wainwright, reiterates coverage on Enlivex Therapeutics (ENLV) in the Healthcare sector with a Buy rating and a price target of $ 15 (1 month ago).
Click for complete article >>--------------------------------------------------------------------------
Frequency Therapeutics
Symbol: FREQ
Recent Price: $1.88
Average Analyst Price Target: $10.00 (431.91%)
Last Year's EPS: -$0.73
Consensus EPS Forecast: -$0.57
Expected Earnings Date: Nov 20 2022
Recent Analyst Action: Jack Allen, analyst at Robert W. Baird, reiterates coverage on Frequency Therapeutics (FREQ) in the Healthcare sector with a Buy rating and a price target of $ 10 (1 week ago).
Click for complete article >>--------------------------------------------------------------------------
Ibio
Symbol: IBIO
Recent Price: $1.71
Average Analyst Price Target: $3.63 (112.28%)
Last Year's EPS: -$1
Consensus EPS Forecast: -$25.38
Expected Earnings Date: Nov 20 2022
Recent Analyst Action: Roy Buchanan, analyst at JMP Securities, reiterates coverage on Ibio (IBIO) in the Healthcare sector with a Buy rating and a price target of $ 3 (22 hours ago).
Click for complete article >>--------------------------------------------------------------------------
To Your Financial Future,
The Editor, HealthTechMovers.com
